HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oskar Haas Selected Research

Oskar Haas Research Topics

Disease

2Neoplasms (Cancer)
08/2022 - 01/2018
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2022 - 01/2010
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2014 - 03/2003
1Hepatocellular Carcinoma (Hepatoma)
02/2018
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2018
1Pdgfra-Associated Chronic Eosinophilic Leukemia
04/2014
1Leukemia
01/2010
1Neuroendocrine Tumors (Neuroendocrine Tumor)
06/2009
1Rett Syndrome (Rett's Disorder)
05/2007
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2006
1Lymphoma (Lymphomas)
04/2006

Drug/Important Bio-Agent (IBA)

1MutagensIBA
02/2018
1Imatinib Mesylate (Gleevec)FDA Link
04/2014
1Oncogene Proteins (Oncogene Protein)IBA
04/2014
1Peroxidase (Myeloperoxidase)IBA
01/2010
1glycocyamineIBA
05/2007
1CreatineIBA
05/2007
1CreatinineIBA
05/2007
1HomocysteineIBA
05/2007
1Methionine (L-Methionine)FDA Link
05/2007
1Anaplastic Lymphoma KinaseIBA
04/2006
1Interleukin-7 (Interleukin 7)IBA
03/2003
1Neoplasm Antigens (Tumor Antigens)IBA
03/2003
1AntigensIBA
03/2003

Therapy/Procedure

3Therapeutics
01/2018 - 06/2009
1Aftercare (After-Treatment)
08/2022
1ICE protocol 4
01/2014